Related Experiment Video
Updated: Mar 22, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA‑451 protects against cardiomyocyte anoxia/reoxygenation injury by inhibiting high mobility group box 1
Jing Xie1, Xiaorong Hu1, Chunfeng Yi1
1Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Abstract:
High mobility group box 1 (HMGB1) protein serves an important role in myocardial ischemia/reperfusion (I/R) injury. MicroRNAs (miRNAs) are a group of small non‑coding RNAs that regulate numerous signaling pathways involved in myocardial I/R injury. The present study aimed to investigate whether miR‑451 protects against cardiomyocyte anoxia/reoxygenation (A/R) injury by attenuating HMGB1 expression. Neonatal rat ventricular cardiomyocytes were prepared and then subjected to A/R injury. The effect of upregulation or downregulation of miR‑451 on cell viability, apoptosis, superoxide dismutase (SOD) activity, and the expression of cleaved‑caspase‑3 and HMGB1 were measured accordingly. A luciferase assay was performed to further confirm whether miR‑451 can directly recognize the 3'‑untranslated region of HMGB1 in HEK293 cells. The expression of miR‑451 was significantly decreased in the cardiomyocytes during A/R, and upregulation of miR‑451 led to increased miR‑451 expression (P<0.05). Upregulation of miR‑451 significantly attenuated the loss of cardiomyocyte viability (P<0.05) and increased the intracellular levels of SOD during A/R (P<0.05). Furthermore, upregulation of miR‑451 significantly decreased the apoptosis of cardiomyocytes during A/R (P<0.05). The HMGB1 mRNA and protein expression levels were significantly downregulated in the Ad‑miR‑451 group compared with those in the A/R group (P<0.05). In addition, upregulation of miR‑451 reduced its translocation from the nucleus to the cytoplasm. The luciferase assay confirmed that HMGB1 mRNA is a direct target of miR‑451 in cardiomyocytes. In conclusion, the present study suggested that upregulation of miR‑451 could protect against A/R‑induced cardiomyocyte injury by inhibiting HMGB1 expression.
Insights
MicroRNA-451 (miR-451) protects heart cells from damage during anoxia/reoxygenation (A/R) injury. Upregulating miR-451 reduces High mobility group box 1 (HMGB1) expression, mitigating cardiac A/R injury.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- High mobility group box 1 (HMGB1) protein is implicated in myocardial ischemia/reperfusion (I/R) injury.
- MicroRNAs (miRNAs) are key regulators in cardiac I/R injury pathways.
Purpose of the Study:
- To investigate the protective role of miR-451 against cardiomyocyte anoxia/reoxygenation (A/R) injury.
- To determine if miR-451 attenuates HMGB1 expression in cardiac A/R injury.
Main Methods:
- Neonatal rat ventricular cardiomyocytes subjected to A/R injury.
- Assessed cell viability, apoptosis, superoxide dismutase (SOD) activity, and cleaved-caspase-3 expression.
- Utilized a luciferase assay to confirm direct targeting of HMGB1 by miR-451.
Main Results:
- miR-451 expression decreased during A/R; upregulation enhanced cell viability and SOD activity.
- Upregulation of miR-451 significantly reduced cardiomyocyte apoptosis and HMGB1 expression (mRNA and protein).
- Luciferase assay confirmed HMGB1 mRNA as a direct target of miR-451.
Conclusions:
- Upregulation of miR-451 confers protection against A/R-induced cardiomyocyte injury.
- miR-451 exerts its protective effects by inhibiting HMGB1 expression.
- miR-451 represents a potential therapeutic target for managing cardiac A/R injury.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs

